AI System Detects Cardiac Events in Cancer Patients' Records

Patients with breast and lung cancer are at a heightened risk of cardiotoxicity, a heart‑related damage caused by cancer therapies. The close anatomical proximity of the heart to the breast and lung tissues makes these patients more vulnerable to treatment‑induced cardiac injury, which can progress to heart attacks, heart failure and other serious cardiovascular conditions.

Identifying evidence of cardiac disease in this population normally requires sifting through the medical records of hundreds of patients. The sheer volume of documentation makes manual review impractical, leading to delays in detecting early signs of cardiotoxicity and potentially compromising timely intervention.

The time‑consuming nature of traditional record‑review methods highlights a significant barrier to efficient cardiac monitoring in breast and lung cancer patients, underscoring the need for more streamlined approaches to safeguard cardiovascular health during cancer treatment.